Detalhe da pesquisa
1.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485231
2.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol
; 216: 107941, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622940
3.
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Microb Pathog
; 137: 103783, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600536
4.
A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.
Parasitol Res
; 115(4): 1649-58, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26782811
5.
Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins.
Vet Parasitol
; 296: 109513, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225189
6.
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
Immunol Lett
; 220: 11-20, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981576
7.
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.
Acta Trop
; 203: 105318, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870709
8.
Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
Immunobiology
; 224(1): 163-171, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266201
9.
Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls.
Diagn Microbiol Infect Dis
; 95(2): 134-143, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155395
10.
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up.
Diagn Microbiol Infect Dis
; 92(3): 196-203, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941364
11.
Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice.
Acta Trop
; 171: 8-16, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28288798
12.
A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
Parasit Vectors
; 8: 363, 2015 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160291
13.
Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.
Clin Vaccine Immunol
; 21(1): 96-106, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24256622